Alloy Therapeutics vs Crown Bioscience
Alloy Therapeutics vs Crown Bioscience, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alloy Therapeutics is on 51/100 and Crown Bioscience on 54/100.
Where each one leads
Alloy Therapeutics
Leads on none of the measures we hold for both companies.
Crown Bioscience
- our overall score: 54/100 against 51/100
- agent readiness: 48/100 against 39/100
- domain rating: 59/100 against 47/100
- funding raised: $262M against $157M
At a glance
| Measure | Alloy Therapeutics | Crown Bioscience |
|---|---|---|
| What it is | A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services. | A global contract research organization specializing in preclinical and translational oncology research. |
| Category | Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development | Drug Discovery, Biotech, Oncology, Contract Research Organization |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2006 |
| Headquarters | Boston, USA | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alloy Therapeutics | Crown Bioscience |
|---|---|---|
| Total funding | $157M | $262M |
| Latest round | Series E | Acquisition |
| Valuation | $1.0B | $640M |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alloy Therapeutics | Crown Bioscience |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 54/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 15/100 | 18/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (48/100) |
| Domain ratingLink authority, 0-100 | 47/100 | 59/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alloy Therapeutics | Crown Bioscience |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager, Segment, Hotjar +1 more |
| Support stack | HubSpot | Drift |
Alloy Therapeutics vs Crown Bioscience: common questions
Which is better, Alloy Therapeutics or Crown Bioscience?
On our 0-100 score Crown Bioscience rates higher (54/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Alloy Therapeutics and Crown Bioscience compare on the numbers?
Crown Bioscience leads on our overall score (54/100 against 51/100), agent readiness (48/100 against 39/100), domain rating (59/100 against 47/100), funding raised ($262M against $157M).
Read the full Alloy Therapeutics review and pricing or the Crown Bioscience review and pricing. You can also browse other Alloy Therapeutics alternatives we track.